CTT Pharmaceutical Holdings, Inc. (CTTH) stock
CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026Market cap $1.26MP/E –Yield –
CTT Pharmaceutical cash
Cash and short-term investments held at the end of each period.
CTT Pharmaceutical's cash was $32.12K at Sep 30, 2015. For fiscal 2014 it was $81.18K. The highest annual figure on record is $569.38K in fiscal 2011.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $81.18K | – |
| FY2013 | Dec 31, 2013 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $164.33K | -71.1% |
| FY2011 | Dec 31, 2011 | $569.38K | +1132.7% |
| FY2010 | Dec 31, 2010 | $46.19K | -83.0% |
| FY2009 | Dec 31, 2009 | $271.17K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2015 | Sep 30, 2015 | $32.12K | -74.4% |
| Q2 FY2015 | Jun 30, 2015 | $46.07K | +1155.7% |
| Q1 FY2015 | Mar 31, 2015 | $73.45K | +1516.0% |
| Q4 FY2014 | Dec 31, 2014 | $81.18K | – |
| Q3 FY2014 | Sep 30, 2014 | $125.32K | – |
| Q2 FY2014 | Jun 30, 2014 | $3.67K | -53.7% |
| Q1 FY2014 | Mar 31, 2014 | $4.55K | -76.1% |
| Q4 FY2013 | Dec 31, 2013 | $0 | -100.0% |
| Q3 FY2013 | Sep 30, 2013 | $0 | -100.0% |
| Q2 FY2013 | Jun 30, 2013 | $7.92K | -98.4% |
| Q1 FY2013 | Mar 31, 2013 | $19.00K | -98.5% |
| Q4 FY2012 | Dec 31, 2012 | $164.33K | -71.1% |
| Q3 FY2012 | Sep 30, 2012 | $210.25K | -70.0% |
| Q2 FY2012 | Jun 30, 2012 | $503.02K | -41.7% |
| Q1 FY2012 | Mar 31, 2012 | $1.26M | +217.6% |
| Q4 FY2011 | Dec 31, 2011 | $569.38K | +1132.7% |
| Q3 FY2011 | Sep 30, 2011 | $701.62K | +90.0% |
| Q2 FY2011 | Jun 30, 2011 | $862.35K | -34.9% |
| Q1 FY2011 | Mar 31, 2011 | $396.01K | -78.4% |
| Q4 FY2010 | Dec 31, 2010 | $46.19K | -83.0% |
| Q3 FY2010 | Sep 30, 2010 | $369.22K | – |
| Q2 FY2010 | Jun 30, 2010 | $1.32M | – |
| Q1 FY2010 | Mar 31, 2010 | $1.83M | – |
| Q4 FY2009 | Dec 31, 2009 | $271.17K | – |
See a number that looks wrong?